乾貨諮訊

A New Era of Metabolic Health: How the Dual-Tar...

Globally, the prevalence of obesity and type 2 diabetes continues to rise, becoming major chronic diseases affecting human health. While traditional hypoglycemic drugs and weight management methods have some efficacy,...

A New Life for Diabetics: Trelagagliptin Succin...

The first rays of sunlight stream through the curtains, beginning the day's fixed "ritual"—not a cup of coffee, but a finger prick for blood, an insulin injection, or the swallowing...

From Lab to Shelf: The Journey to the Birth of ...

When you pick up a small vial of Lisudil eye drops and gently drop it into your eyes, hoping it will relieve your dry eye discomfort and bring you clear...

Trelagliptin Succinate Tablets: A caring partne...

Have you ever felt overwhelmed on your journey to control your blood sugar? Especially when facing the daunting task of "weight loss," do you feel helpless and frustrated? We all...

Reshaping Health: From Principles to Effects, a...

Have you ever experienced this dilemma: dieting relentlessly, yet your weight remains stubbornly unchanged? Exercising intensely, yet your waistline doesn't shrink? Faced with the temptation of delicious food, your inner...

Eli Lilly's tesipatide: A scientific breakthrou...

Tirzepatide, developed by Eli Lilly and Company of Japan, is the world's first dual GIP/GLP-1 receptor agonist, representing a major breakthrough in the treatment of diabetes.